Stay updated on HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdministrative updates include adding Revision: v3.4.2 and removing a government funding status notice as well as Revision: v3.4.1; these changes do not affect the study details, eligibility criteria, or results information.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding and NIH operations was added, and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedThe updates are UI labeling and metadata changes: a new 'Show glossary' option was added and QC-related labels were adjusted (e.g., capitalization of 'Met QC Criteria'). The revision/version was updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page, with no visible changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing study sites by state (Arizona, California, Florida, Maryland, Texas) and updated the page revision to v3.3.3. The previous per-state location headings (Arizona Locations, California Locations, etc.) were removed.SummaryDifference0.6%

- Check91 days agoChange DetectedAdded revision: v3.3.2 and removed revision: v3.2.0 from the page.SummaryDifference0.1%

Stay in the know with updates to HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.